Dr. Matthew Bott, MD

Claim this profile

Memorial Sloan Kettering

Studies Non-Small Cell Lung Cancer
Studies Lung Adenocarcinoma
2 reported clinical trials
5 drugs studied

Area of expertise

1

Non-Small Cell Lung Cancer

Matthew Bott, MD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage I
Stage III
Stage II
2

Lung Adenocarcinoma

Matthew Bott, MD has run 1 trial for Lung Adenocarcinoma. Some of their research focus areas include:

Stage I

Affiliated Hospitals

Image of trial facility.

Memorial Sloan Kettering

Image of trial facility.

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

More about Matthew Bott, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Matthew Bott, MD has experience with

  • Carboplatin
  • Nivolumab
  • Nivolumab And Ipilimumab
  • Paclitaxel
  • NovoTTF-200T System

Breakdown of trials Matthew Bott, MD has run

Non-Small Cell Lung Cancer

Lung Adenocarcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Matthew Bott, MD specialize in?

Is Matthew Bott, MD currently recruiting for clinical trials?

Are there any treatments that Matthew Bott, MD has studied deeply?

What is the best way to schedule an appointment with Matthew Bott, MD?

What is the office address of Matthew Bott, MD?

Is there any support for travel costs?